Complete response of myeloid sarcoma with FIP1L1-PDGFRA-associated myeloproliferative neoplasms to imatinib mesylate monotherapy

Acta Haematologica

Volumn 128, Issue 2, 2012, Pages 83-87

  Tang, Tzung Chih ^a   Chang, Hung ^a   Chuang, Wen Yu ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

FIP1L1 PDGFRA; Imatinib mesylate; Monotherapy; Myeloid sarcoma

Indexed keywords

FIP1L1 PROTEIN; IMATINIB; PDGFRA PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE MARROW BIOPSY; BONE PAIN; CANCER DIAGNOSIS; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; FATIGUE; FEVER; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GRANULOCYTIC SARCOMA; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LEG EDEMA; LYMPHADENOPATHY; MALE; MONOTHERAPY; MYELOPROLIFERATIVE NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SPLENOMEGALY; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR BIOPSY; WEIGHT REDUCTION;

ADULT; HUMANS; MALE; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; MYELOPROLIFERATIVE DISORDERS; PIPERAZINES; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; SARCOMA, MYELOID;

EID: 84862506066     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000338217     Document Type: Article

References (24)

1. Pileri SA, Ascani S, Cox MC, Campidelli C, Bacci F, Piccioli M, Piccaluga PP, Agostinelli C, Asioli S, Novero D, Bisceglia M, Ponzoni M, Gentile A, Rinaldi P, Franco V, Vincelli D, Pileri A Jr, Gasbarra R, Falini B, Zinzani PL, Baccarani M: Myeloid sarcoma: clinicopathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 2007; 21: 340-350. (Pubitemid 46158129)
2. Paydas S, Zorludemir S, Ergin M: Granulocytic sarcoma: 32 cases and review of the literature. Leuk Lymphoma 2006; 47: 2527-2541. (Pubitemid 44932643)
3. Yamauchi K, Yasuda M: Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer 2002; 94: 1739-1746. (Pubitemid 34241112)
4. Tefferi A, Vardiman JW: Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008; 22: 14-22.
5. Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, Kutok J, Clark J, Galinsky I, Griffin JD, Cross NC, Tefferi A, Malone J, Alam R, Schrier SL, Schmid J, Rose M, Vandenberghe P, Verhoef G, Boogaerts M, Wlodarska I, Kantarjian H, Marynen P, Coutre SE, Stone R, Gilliland DG: A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003; 348: 1201-1214. (Pubitemid 36359296)
6. Vandenberghe P, Wlodarska I, Michaux L, Zachee P, Boogaerts M, Vanstraelen D, Herregods MC, Van Hoof A, Selleslag D, Roufosse F, Maerevoet M, Verhoef G, Cools J, Gilliland DG, Hagemeijer A, Marynen P: Clinical and molecular features of FIP1L1-PDGFRA (+) chronic eosinophilic leukemias. Leukemia 2004; 18: 734-742. (Pubitemid 38500191)
7. Cozzi P, Nosari A, Cantoni S, Ribera S, Pungolino E, Lizzadro G, Oreste P, Asnaghi D, Morra E: Traumatic left shoulder fracture masking aggressive granuloblastic sarcoma in a cml patient. Haematologica 2004; 89:EIM15.
8. Kuan JW, Pathmanathan R, Chang KM, Tan SM: Aleukemic bcr-abl positive granulocytic sarcoma. Leuk Res 2009; 33: 1574-1577.
9. Bakst RL, Tallman MS, Douer D, Yahalom J: How I treat extramedullary acute myeloid leukemia. Blood 2011; 118: 3785-3793.
10. Avni B, Rund D, Levin M, Grisariu S, Ben-Yehuda D, Bar-Cohen S, Paltiel O: Clinical implications of acute myeloid leukemia presenting as myeloid sarcoma. Hematol Oncol 2012; 30: 34-40.
11. Breccia M, Mandelli F, Petti MC, D'Andrea M, Pescarmona E, Pileri SA, Carmosino I, Russo E, De Fabritiis P, Alimena G: Clinicopathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single institution. Leuk Res 2004; 28: 1165-1169. (Pubitemid 39243240)
12. Cho SF, Liu YC, Tsai HJ, Lin SF: Myeloid sarcoma mimicking nasopharyngeal carcinoma. J Clin Oncol 2011; 29:e706-708.
13. Chevallier P, Labopin M, Cornelissen J, Socie G, Rocha V, Mohty M: Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: a report from the acute leukemia working party of the European group for blood and marrow transplantation. Haematologica 2011; 96: 1391-1394.
14. Metzgeroth G, Walz C, Score J, Siebert R, Schnittger S, Haferlach C, Popp H, Haferlach T, Erben P, Mix J, Muller MC, Beneke H, Muller L, Del Valle F, Aulitzky WE, Wittkowsky G, Schmitz N, Schulte C, Muller-Hermelink K, Hodges E, Whittaker SJ, Diecker F, Dohner H, Schuld P, Hehlmann R, Hochhaus A, Cross NC, Reiter A: Recurrent finding of the FIP1L1-PDFGRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma. Leukemia 2007; 21: 1183-1188. (Pubitemid 46831806)
15. von Bubnoff N, Sandherr M, Schlimok G, Andreesen R, Peschel C, Duyster J: Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alphapositive chronic myeloproliferative disease with prominent eosinophilia. Leukemia 2005; 19: 286-287. (Pubitemid 40220595)
16. Sekkach Y, Mekouar F, Jira M, Elqatni M, Elomri N, Fatihi J, Badaoui M, Hammi S, Smaali J, El Khattabi A, Amezyane T, Abouzahir A, Ghafir D: Durable efficacity and remission after treatment with imatinib mesylate for FIP1L1-PDGFRA transcript negative associated eosinophilic cardiomyopathy (in French). Ann Pharm Fr 2011; 69: 277-281.
17. Awano N, Ryu T, Yoshimura N, Takazoe M, Kitamura S, Tanaka M: Successful treatment of ulcerative colitis associated with hypereosinophilic syndrome/chronic eosinophilic leukemia. Intern Med 2011; 50: 1741-1745.
18. Helbig G, Hus M, Halasz M, Dudzinski M, Wieclawek A, Stachowicz M, Soja A, Kyrcz-Krzemien S: Imatinib mesylate may induce long-term clinical response in FIP1L1-PDGFR-negative hypereosinophilic syndrome. Med Oncol 2012; 29: 1073-1076.
19. Chan SW, Datta NN, Thomas TM, Chan KW: Intracranial chloroma in hypereosinophilic myelofibrosis. Surg Neurol 2003; 59: 55-57. (Pubitemid 36300812)
20. Lynott A, Ravandi-Kashani F, Giles FJ: Malignancy: case report: hypereosinophilia progressing to granulocytic sarcoma and acute myelocytic leukemia with trisomy 8: a case report and review of the literature. Hematology 2000; 4: 487-493. (Pubitemid 30216424)
21. Fujii N, Ikeda K, Takahashi N, Kojima K, Kobayashi Y, Ashiba A, Takenaka K, Fukuda S, Shinagawa K, Ishimaru F, Niiya K, Miura I, Tanimoto M, Harada M: Multilineage involvement in hypereosinophilic syndrome terminating in granulocytic sarcoma and leukaemic transformation with trisomy 8. Br J Haematol 2002; 119: 716-719. (Pubitemid 35366214)
22. Vedy D, Muehlematter D, Rausch T, Stalder M, Jotterand M, Spertini O: Acute myeloid leukemia with myeloid sarcoma and eosinophilia: prolonged remission and molecular response to imatinib. J Clin Oncol 2010; 28:e33-e35.
23. Helbig G, Moskwa A, Hus M, Piszcz J, Swiderska A, Urbanowicz A, Calbecka M, Seferynska I, Razny M, Rodzaj M, Zuk E, Kyrcz-Krzemien S: Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFR-positive chronic eosinophilic leukaemia. Cancer Chemother Pharmacol 2011; 67: 967-969.
24. Jovanovic JV, Score J, Waghorn K, Cilloni D, Gottardi E, Metzgeroth G, Erben P, Popp H, Walz C, Hochhaus A, Roche-Lestienne C, Preudhomme C, Solomon E, Apperley J, Rondoni M, Ottaviani E, Martinelli G, Brito-Babapulle F, Saglio G, Hehlmann R, Cross NC, Reiter A, Grimwade D: Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood 2007; 109: 4635-4640. (Pubitemid 46827752)